Conference Coverage
Conference Coverage
How Can Kidney Cancer Patients Benefit From New Combination Therapy?
Immunotherapy has expanded treatment options as an adjuvant and a first-line therapy in patients with renal cell carcinoma.
Conference Coverage
How Long Should Active Surveillance Last?
New data “suggest that meticulous follow-up is needed over a longer time” than previous studies have shown.
Conference Coverage
Blood Test Shows Promise for Improving CRC Screening
Researchers evaluate new cfDNA blood-based test’s ability to detect CRC.
Conference Coverage
How New ICI Combos Change Bladder Cancer Management
Immune checkpoint inhibitor combinations have restructured treatment guidelines for metastatic urothelial carcinoma.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Conference Coverage
Ovarian Cancer: Another Promising Target for Liquid Biopsy
A test under development “looks very sensitive for detecting ovarian cancer early.”
Conference Coverage
ALL: Which Life-Saving Tx Is Best?
Both CAR T-cell therapy and bispecific antibodies are helping patients with patients with R/R ALL live longer, but which treatment is better?
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Conference Coverage
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 Expression
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric...
